These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 7511134)

  • 1. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings.
    Insler V; Shoham Z; Barash A; Koistinen R; Seppälä M; Hen M; Lunenfeld B; Zadik Z
    Hum Reprod; 1993 Mar; 8(3):379-84. PubMed ID: 7682564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
    Rasmussen MH; Juul A; Hilsted J
    Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
    Abd El Aal DE; Mohamed SA; Amine AF; Meki AR
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):219-24. PubMed ID: 15653207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
    Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered regulation of insulin-like growth factor binding protein-1 in patients with polycystic ovary syndrome.
    Carmina E; Stanczyk FZ; Morris RS; Lee PD; Savjani G; Lobo RA
    J Soc Gynecol Investig; 1995; 2(6):743-7. PubMed ID: 9420884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovary disease.
    Martínez-Guisasola J; Guerrero M; Alonso F; Díaz F; Cordero J; Ferrer J
    Gynecol Endocrinol; 2001 Feb; 15(1):14-22. PubMed ID: 11293919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome: evolution of a concept.
    Ruutiainen K; Seppälä M
    Curr Opin Obstet Gynecol; 1991 Jun; 3(3):326-35. PubMed ID: 1813001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.